Molecule Information
General Information of the Molecule (ID: Mol05042)
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Breast cancer [ICD-11: 2C60.2] | [1] | |||
| Resistant Disease | Breast cancer [ICD-11: 2C60.2] | |||
| Resistant Drug | Docetaxel | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | BT-20 cells | Mammary gland | Homo sapiens (Human) | CVCL_0178 |
| BT-474 cells | Breast | Homo sapiens (Human) | CVCL_0179 | |
| BT-549 cells | Breast | Homo sapiens (Human) | CVCL_1092 | |
| CAMA-1 cells | Breast | Homo sapiens (Human) | CVCL_1115 | |
| HCC1143 cells | Breast | Homo sapiens (Human) | CVCL_1245 | |
| HCC1806 cells | Breast | Homo sapiens (Human) | CVCL_1258 | |
| HCC1937 cells | Breast | Homo sapiens (Human) | CVCL_0290 | |
| HCC1954 cells | Breast | Homo sapiens (Human) | CVCL_1259 | |
| HCC38 cells | Breast | Homo sapiens (Human) | CVCL_1267 | |
| HCC70 cells | Breast | Homo sapiens (Human) | CVCL_1270 | |
| Hs578T cells | Breast | Homo sapiens (Human) | CVCL_0332 | |
| MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 | |
| MDA-MB-231 cells | Breast | Homo sapiens (Human) | CVCL_0062 | |
| MDA-MB-361 cells | Breast | Homo sapiens (Human) | CVCL_0620 | |
| MDA-MB-436 cells | Breast | Homo sapiens (Human) | CVCL_0623 | |
| MDA-MB-468 cells | Breast | Homo sapiens (Human) | CVCL_0419 | |
| SK-BR-3 cells | Pleural effusion | Homo sapiens (Human) | CVCL_0033 | |
| T47D cells | Breast | Homo sapiens (Human) | CVCL_0553 | |
| EVSA-T cells | Ascites | Homo sapiens (Human) | CVCL_1207 | |
| Sk-BR-7 cells | Breast | Homo sapiens (Human) | CVCL_5218 | |
| SUM159PT cells | Breast | Homo sapiens (Human) | CVCL_5423/CVCL_5590 | |
| SUM44PE cells | Breast | Homo sapiens (Human) | CVCL_3424 | |
| SUM52PE cells | Breast | Homo sapiens (Human) | CVCL_3425 | |
| Experiment for Molecule Alteration |
Microarray analyses | |||
| Mechanism Description | This gene is up-regulated in docetaxel-resistance cells | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Breast cancer [ICD-11: 2C60.2] | [2] | |||
| Resistant Disease | Breast cancer [ICD-11: 2C60.2] | |||
| Resistant Drug | Doxorubicin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 |
| MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 | |
| Experiment for Molecule Alteration |
MiRNA microarray; RT-PCR; Western blot | |||
| Experiment for Drug Resistance |
MTT assay | |||
| Mechanism Description | MicroRNAs play important roles in regulation of gene expression involved in crucial biological processes including development, differentiation, apoptosis, and proliferation through down-regulation of target mRNA by degrading them or inhibiting their translation, and specific inhibition of MAPK signaling is important in the regulation of MCF-7/AdrVp cells resistance to chemotherapy drug. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Breast cancer [ICD-11: 2C60.2] | [1] | |||
| Resistant Disease | Breast cancer [ICD-11: 2C60.2] | |||
| Resistant Drug | Paclitaxel | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | BT-20 cells | Mammary gland | Homo sapiens (Human) | CVCL_0178 |
| BT-474 cells | Breast | Homo sapiens (Human) | CVCL_0179 | |
| BT-549 cells | Breast | Homo sapiens (Human) | CVCL_1092 | |
| CAMA-1 cells | Breast | Homo sapiens (Human) | CVCL_1115 | |
| HCC1143 cells | Breast | Homo sapiens (Human) | CVCL_1245 | |
| HCC1806 cells | Breast | Homo sapiens (Human) | CVCL_1258 | |
| HCC1937 cells | Breast | Homo sapiens (Human) | CVCL_0290 | |
| HCC1954 cells | Breast | Homo sapiens (Human) | CVCL_1259 | |
| HCC38 cells | Breast | Homo sapiens (Human) | CVCL_1267 | |
| HCC70 cells | Breast | Homo sapiens (Human) | CVCL_1270 | |
| Hs578T cells | Breast | Homo sapiens (Human) | CVCL_0332 | |
| MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 | |
| MDA-MB-231 cells | Breast | Homo sapiens (Human) | CVCL_0062 | |
| MDA-MB-361 cells | Breast | Homo sapiens (Human) | CVCL_0620 | |
| MDA-MB-436 cells | Breast | Homo sapiens (Human) | CVCL_0623 | |
| MDA-MB-468 cells | Breast | Homo sapiens (Human) | CVCL_0419 | |
| SK-BR-3 cells | Pleural effusion | Homo sapiens (Human) | CVCL_0033 | |
| T47D cells | Breast | Homo sapiens (Human) | CVCL_0553 | |
| EVSA-T cells | Ascites | Homo sapiens (Human) | CVCL_1207 | |
| Sk-BR-7 cells | Breast | Homo sapiens (Human) | CVCL_5218 | |
| SUM159PT cells | Breast | Homo sapiens (Human) | CVCL_5423/CVCL_5590 | |
| SUM44PE cells | Breast | Homo sapiens (Human) | CVCL_3424 | |
| SUM52PE cells | Breast | Homo sapiens (Human) | CVCL_3425 | |
| Experiment for Molecule Alteration |
Microarray analyses | |||
| Mechanism Description | This gene is up-regulated in paclitaxel-resistance cells | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Breast cancer [ICD-11: 2C60.2] | [2] | |||
| Resistant Disease | Breast cancer [ICD-11: 2C60.2] | |||
| Resistant Drug | Verapamil | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 |
| MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 | |
| Experiment for Molecule Alteration |
MiRNA microarray; RT-PCR; Western blot | |||
| Experiment for Drug Resistance |
MTT assay | |||
| Mechanism Description | MicroRNAs play important roles in regulation of gene expression involved in crucial biological processes including development, differentiation, apoptosis, and proliferation through down-regulation of target mRNA by degrading them or inhibiting their translation, and specific inhibition of MAPK signaling is important in the regulation of MCF-7/AdrVp cells resistance to chemotherapy drug. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
